Appleton W.S. (1968) The false drug side-effect. Which patients complain . Br J Psychiatr114: 197-201
2.
Ayd F.J. (1969) Phenothiazine-induced agranulocytosis: the 'at risk' patient. Int Drug Ther Newslett4: 13-20
3.
Barnes C.G. (1974) Medical disorders in obstetric practice. Blackwell Scientific Publications, London
4.
Barnes T R E (1990) Movement disorder associated with antipsychotic drugs: the tardive syndromes. Int Rev Psychiatr2: 355-366
5.
Barnes T R E (1992) Clinical assessment of the extrapyramidal side effects of antipsychotic drugs. J Psychopharmacol6: 214-221
6.
Blackwell B., Marley E., Price J., Taylor D. (1967) Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs. Br J Psychiatr113: 349-365
7.
deGruchy G.C. (1975) Drug-induced blood disorders. Blackwell Scientific Publications, London
8.
Edwards J.G. (1981) Unwanted effects of psychotropic drugs and their mechanisms. In van Praag H M, Lader M H, Raphaelson O J , Sacher E J (eds), Handbook of biological psychiatry, part VI. Practical applications of psychotropic drugs and other biological treatments. Marcel Dekker, New York, pp. 1-38
9.
Edwards J.G. (1985) Antidepressants and seizures. In Trimble M R (ed.), The Psychopharmacology of epilepsy. John Wiley and Sons, Chichester, pp. 119-139
10.
Edwards J.G. (1986) The untoward effects of antipsychotic drugs: pathogenesis and management. In Bradley B P, Hirsch S R (eds), The psychopharmacology and treatment of schizophrenia. Oxford University Press, Oxford, pp. 403-441
11.
Edwards J.G., Glenn-Bott M. (1983). Mianserin and convulsive seizures. Br J Clin Pharmacol15(Suppl. 2): 299-311
12.
Edwards J.G., Wheal H.V. (1992) Assessment of epileptogenic potential: experimental, clinical and epidemiological approaches. J Psychopharmacol6: 204-213
13.
Edwards J.G., Long S.K., Sedgwick E.M., Wheal H.V. (1986) Antidepressants and convulsive seizures: clinical, electroencephalographic, and pharmacological aspects. Clin Neuropharmacol9: 329-360
14.
Girdwood R.H. (1976) Drug-induced haematological abnormalities. In Israels M C G, Delaware I W (eds), Haematological aspects of systemic disease . W B Saunders, London, pp. 495-528
15.
Gordon-Smith E D, ed. (1980) Haematological effects of drug therapy. Clin Haematol9: 455-691
16.
Greenberg G., Inman W H W, Weatherall J A C, Adelstein A.M., Haskey J.C. (1977) Maternal drug histories and congenital abnormalities . Br Med J2: 853-856
17.
Guy W. ( 1976) ECDEU. Assessment manual for psychopharmacology, revised edition. US Department of Health, Education and Welfare , Washington, DC
18.
Hawkins D.F. (1992) Assessment of teratogenicity. J Psychopharmacol6: 225-229
19.
Hindmarch I., Barwell F., Alford C. (1991) Behavioural toxicity of antidepressants. In Leonard B E, Spencer P (eds), Antidepressants: 30 years on. CNS Publishers, London, pp. 403-409
20.
Hindmarch I., Alford C., Barwell F., Kerr J.S. (1992) Measuring the side effects of psychotropics: the behavioural toxicity of antidepressants. J Psychopharmacol6: 198-203
21.
Hoffbrand A.V., Veys P.A., Wilkes S. (1992) Investigation of psychotropic drug-induced blood agranulocytosis. J Psychopharmacol6: 222-224
22.
Jick H., Miettinen O.S., Shapiro S., Lewis G.P., Siskind V., Slone D. (1970) Comprehensive drug surveillance. J Am Med Assoc213: 1455-1460
23.
Lawson D.H. (1980) Intensive monitoring in hospitals. I: Boston Collaborative Drug Surveillance Program. In Inman W H W (eds), MTP Press, Lancaster , pp. 213-240
24.
Lewis J.A. (1981) Post-marketing surveillance: how many patients . Trends Pharmacol Sci2: 93-94
25.
Logothetis J. (1967) Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy. Neurology17: 869-877
26.
Mindham R H S (1976) Assessment of drug-induced extrapyramidal reactions and of drugs given for their control. Br J Clin Pharmacol Suppl.: 395-400
27.
Moya F., Thorndyke V. (1962) Passage of drugs across the placenta. Am J Obstet Gynecol84: 1778-1798
28.
Nelson M.M., Forfar J.O. (1971) Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J1 : 523-527
29.
Pisciotta A.V. (1968) Mechanisms of phenothiazine induced agranulocytosis . In Efron D F (ed.), Psychopharmacology, a review of progress, 1957-1967. US Government Printing Office, Washington DC, pp. 597-605
30.
Pisciotta A.V. (1973) Immune and toxic mechanisms in drug-induced agranulocytosis . Seminars Haematol10: 279-310Pisciotta A.V. (1974) The effect of chlorpromazine on peripheral leukocytes. In Dimitrov N V, Nodine J H (eds), Drugs and hematologic reactions. Grune and Stratten, New York, pp. 233-247
31.
Pogge R.C. (1963) The toxic placebo. Med Times91: 773-778Rawlins M.D., Thompson J.W. (1977) Pathogenesis of adverse drug reactions. In Davis, D M (ed.), Textbook of adverse drug reactions. Oxford University Press , Oxford, pp. 10-31
32.
Rawson N S B, Pearce G.L., Inman W H W (1990) Prescription-event monitoring: methodology and recent progress. J Clin Epidemiol43: 503-522
Royal College of General Practitioners (1975 ) Morbidity and drugs in pregnancy. J R Coll Gen Practitioners25: 631-645
35.
Samuel G., Blackwell B. (1968) Mono-amine oxidase inhibitors and cheese: a process of discovery. Hosp Med2: 942-943
36.
Schou M., Goldfield M.D., Weinstein M.R., Villeneuve A. (1973) Lithium and pregnancy—I. Report from the register of lithium babies. Br Med J1: 135-136Simpson G.M., Angus J W S (1970) A rating scale for extrapyramidal side effects . Acta Psychiatr Scand212 (Suppl 44): 11-19
37.
Simpson G.M., Lee J.H., Zoubok B., Cole J.O., Gardos G. (1979) A rating scale for tardive dyskinesia. Psychopharmacology64: 171-179
38.
Swett C. (1975) Outpatient phenothiazine use and bone marrow depression. A report from the drug epidemiology unit and collaborative drug surveillance programme. Arch Gen Psychiatr32: 1416-1418
Trimble M.R. (1978) Non-monoamine oxidase inhibitor antidepressants and epilepsy. A review. Epilepsia19: 241-250
41.
Webster D.D. (1968) Clinical analysis of the disability in parkinsons' disease. Modern Treatments5: 257-282
42.
Weinstein M.R. (1980) Lithium treatment of women during pregnancy and in the post-delivery period. In Johnson F N (eds), Handbook of lithium therapy. MTP Press, Lancaster, pp. 421-429
43.
Wintrobe M.H., Lee G.R., Boggs D.R., Bithell T.C., Foerster J., Athens J.W., Lukens JN (1981) Clinical hematology. Lea and Febiger, Philadelphia
44.
Witts L.J. (1965) Adverse reactions to drugs. Br Med J2: 1081-1086
45.
Wolf S., Pinsky R.H. (1954) The effects of placebo administration and occurrence of toxic reactions. J Am Med Assoc155: 339-341